Caricamento...
Evidence for using pimavanserin for the treatment of Parkinson's disease psychosis
The aim of this editorial is to evaluate the evidence for using pimavanserin for the treatment of Parkinson's disease psychosis (PDP) from randomized controlled trials (RCTs). We only identified two published trials that evaluated the use of pimavanserin among individuals with PDP. Both studies...
Salvato in:
| Pubblicato in: | World J Psychiatry |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Baishideng Publishing Group Inc
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6560499/ https://ncbi.nlm.nih.gov/pubmed/31211112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5498/wjp.v9.i3.47 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|